101 related articles for article (PubMed ID: 21225235)
1. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.
Choi MS; Kim SH; Kuh HJ
Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.
Lee JW; Park JK; Lee SH; Kim SY; Cho YB; Kuh HJ
Anticancer Drugs; 2006 Apr; 17(4):377-84. PubMed ID: 16549994
[TBL] [Abstract][Full Text] [Related]
3. Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells.
Kim KS; Kim SH; Im CN; Na K; Lee MY; Park JK; Kuh HJ
Biochem Biophys Res Commun; 2023 Mar; 647():30-36. PubMed ID: 36709670
[TBL] [Abstract][Full Text] [Related]
4. The distribution and retention of paclitaxel and doxorubicin in multicellular layer cultures.
Lee JH; Na K; Song SC; Lee J; Kuh HJ
Oncol Rep; 2012 Apr; 27(4):995-1002. PubMed ID: 22267208
[TBL] [Abstract][Full Text] [Related]
5. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells.
Grantab R; Sivananthan S; Tannock IF
Cancer Res; 2006 Jan; 66(2):1033-9. PubMed ID: 16424039
[TBL] [Abstract][Full Text] [Related]
6. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
7. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of interstitial protein delivery in multicellular layers model.
Kim SY; Kim TH; Choi JH; Lee KC; Park KD; Lee SJ; Kuh HJ
Arch Pharm Res; 2012 Mar; 35(3):531-41. PubMed ID: 22477201
[TBL] [Abstract][Full Text] [Related]
9. Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel.
Al-Abd AM; Lee JH; Kim SY; Kun N; Kuh HJ
Cancer Sci; 2008 Feb; 99(2):423-31. PubMed ID: 18271941
[TBL] [Abstract][Full Text] [Related]
10. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
[TBL] [Abstract][Full Text] [Related]
11. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors.
Tunggal JK; Cowan DS; Shaikh H; Tannock IF
Clin Cancer Res; 1999 Jun; 5(6):1583-6. PubMed ID: 10389947
[TBL] [Abstract][Full Text] [Related]
12. Non-nuclear localization of Ki-67 in human colorectal cancer cells grown as multicellular layers.
Kim YJ; Lee SH; Lee J; Kuh HJ
Arch Pharm Res; 2013 May; 36(5):634-40. PubMed ID: 23536320
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
[TBL] [Abstract][Full Text] [Related]
14. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing.
Zhang X; Wang W; Yu W; Xie Y; Zhang X; Zhang Y; Ma X
Biotechnol Prog; 2005; 21(4):1289-96. PubMed ID: 16080713
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
Serpe L; Catalano MG; Cavalli R; Ugazio E; Bosco O; Canaparo R; Muntoni E; Frairia R; Gasco MR; Eandi M; Zara GP
Eur J Pharm Biopharm; 2004 Nov; 58(3):673-80. PubMed ID: 15451544
[TBL] [Abstract][Full Text] [Related]
17. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.
Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M
Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385
[TBL] [Abstract][Full Text] [Related]
18. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
19. A mathematical model of doxorubicin penetration through multicellular layers.
Evans CJ; Phillips RM; Jones PF; Loadman PM; Sleeman BD; Twelves CJ; Smye SW
J Theor Biol; 2009 Apr; 257(4):598-608. PubMed ID: 19183560
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
